10.09

1.10% 0.11

Gh Research Plc (GHRS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione

Precedente Chiudi:

$9.98

Aprire:

$10.06

Volume 24 ore:

10,631

Relative Volume:

0.05

Capitalizzazione di mercato:

$637.03M

Reddito:

Utile/perdita netta:

$-41.43M

Rapporto P/E:

-12.77

EPS:

-0.79

Flusso di cassa netto:

$-39.97M

1 W Prestazione:

-6.57%

1M Prestazione:

+12.24%

6M Prestazione:

+11.00%

1 anno Prestazione:

-20.80%

Intervallo 1D:

$9.52

$10.28

Intervallo di 1 settimana:

$9.4557

$11.22

Portata 52W:

$6.00

$20.50

Gh Research Plc Stock (GHRS) Company Profile

Nome

Gh Research Plc

Settore

Healthcare (1157)

Industria

Biotechnology (673)

Telefono

Indirizzo

Dipendente

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

GHRS's Discussions on Twitter

Confronta GHRS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
GHRS Gh Research Plc	10.09	637.03M	0	-41.43M	-39.97M	-0.79
VRTX Vertex Pharmaceuticals Inc	432.16	111.66B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	571.84	60.56B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	542.25	38.04B	2.58B	1.06B	-1.28B	16.33
ALNY Alnylam Pharmaceuticals Inc	277.64	36.06B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	225.30	25.10B	3.81B	-644.79M	-669.77M	-6.24

Gh Research Plc Stock (GHRS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-03-13	Iniziato	Guggenheim	Buy
2025-03-07	Iniziato	RBC Capital Mkts	Outperform
2025-02-13	Iniziato	Cantor Fitzgerald	Overweight
2022-08-16	Iniziato	H.C. Wainwright	Buy
2022-06-16	Iniziato	ROTH Capital	Buy

Gh Research Plc Borsa (GHRS) Ultime notizie

07:32 AM

GH Research Showcases Promising Depression Treatment Data at ASCP Meeting - TipRanks

07:32 AM

07:00 AM

GH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual Meeting - TradingView

07:00 AM

May 12, 2025

GH Research’s (GHRS) “Buy” Rating Reiterated at HC Wainwright - Defense World

May 12, 2025

Guggenheim Cuts GH Research (NASDAQ:GHRS) Price Target to $29.00 - Defense World

May 12, 2025

May 10, 2025

GH Research (GHRS) Price Target Lowered by Guggenheim | GHRS Sto - GuruFocus

May 10, 2025

GHRS Stock: HC Wainwright & Co. Reiterates Buy Rating | GHRS Sto - GuruFocus

May 10, 2025

May 08, 2025

GH Research PLC Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025

GHRS Reports Strong Financial Position with Increased Cash Holdi - GuruFocus

May 08, 2025

GH Research Reports Q1 2025 Financial Results Amidst Ongoing Challenges - TipRanks

May 08, 2025

GH Research PLC Reports Positive Phase 2b Trial Results for GH001 in Treatment-Resistant Depression and Financial Update for Q1 2025 - Nasdaq

May 08, 2025

GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates - Stock Titan

May 08, 2025

May 05, 2025

What Makes GH Research (GHRS) a New Buy Stock - Yahoo Finance

May 05, 2025

May 01, 2025

Where are the Opportunities in (GHRS) - news.stocktradersdaily.com

May 01, 2025

Hims & Hers Health (NYSE:HIMS) Shares Down 8.3% Following Insider Selling - American Banking and Market News

May 01, 2025

Apr 21, 2025

Legal & General Group Plc Sells 18,302 Shares of Guardant Health, Inc. (NASDAQ:GH) - Defense World

Apr 21, 2025

Apr 18, 2025

What Will GH Research PLC (NASDAQ: GHRS) Be Like In 2025 - Stocksregister

Apr 18, 2025

Apr 16, 2025

Psyence BioMed invests half a million into natural psychedelics operator PsyLabs - Mugglehead Magazine

Apr 16, 2025

JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Mar 20, 2025

Mar 13, 2025

Guggenheim starts GH Research at Buy, sees long-term upside potential - Yahoo Finance

Mar 13, 2025

Guggenheim Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq

Mar 13, 2025

Mar 11, 2025